by Lori Alton, NaturalHealth365
The news probably comes as no surprise to consumers already suspicious of big pharma: The Daiichi Sankyo Co Ltd, along with its US subsidiary, has been ordered to pay $39 million to the federal government and individual state Medicaid programs.
The judgment comes in answer to a whistleblower lawsuit filed by former pharmaceutical salesperson Kathy Fragoules that accused the companies of paying kickbacks to physicians for prescribing its drugs. And, get this, the company CEO, Joji Nakayama has a vision of “becoming a Global Pharma Innovator.” (is bribery part of his vision?)
Specifically, the lawsuit accused the pharmaceutical company of violating the False Claims Act through the use of lavish meals and speaker program honoraria as avenues for kickbacks to induce physicians to prescribe the drugs Azor, Benicar, Tribenzor, and Welchol.
© 2015 NaturalHealth365.com